Monthly News Roundup - November 2017

FDA Approves Juluca, a Novel 2-Drug Regimen for HIV-1 Infection
In November, the U.S. Food and Drug Administration (FDA) approved ViiV Healthcare ’s Juluca (dolutegravir and rilpivirine), a single-tablet, two-drug regimen of dolutegravir...

Source: Drugs.com - Pharma News - November 30, 2017 Category: Pharmaceuticals Source Type: news